한글목차

세계의 뇌영상 모달리티 시장의 미래는 병원 및 진료소, 화상 진단센터, 외래수술센터(ASC) 시장에 있어서의 기회로 유망시되고 있습니다. 세계의 뇌영상 모달리티 시장은 2025년부터 2031년까지의 CAGR이 4.8%를 나타낼 전망이며, 2031년까지 185억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신경 질환과 외상성 뇌 손상의 유병률 증가, 뇌 영상 양식 및 시스템의 지속적인 기술 진보, 뇌 이미지에서 분자 이미징의 인기가 증가하고 있습니다.

• Lucintel사의 예측에 따르면 제품 카테고리에서는 뇌종양, 뇌졸중, 다발성 경화증 등 다양한 병리를 진단하기 위해 MRI 장치의 채용이 증가하고 있기 때문에 예측 기간 동안 MRI 장치가 가장 높은 성장을 이룰 전망입니다.
• 최종 사용 범주에서는 병원 및 클리닉이 계속해서 최대 부문입니다.
• 지역별로는 신경질환의 유병률 상승, 신기술의 강력한 채용, 지역의 주요 뇌영상 모달리티 제조업체의 존재에 의해 북미가 예측기간을 통해 최대 지역으로 유지하고 있습니다.

뇌 영상 모달리티 시장의 전략적 성장 기회

뇌 영상 모달리티 시장은 다양한 하위 시장을 지배하는 주요 용도과 관련된 전략적 성장 기회로 가득합니다. 이들은 진단, 치료 및 연구의 기술 혁신을 위해 효과적으로 활용할 수 있습니다.

• 신경퇴행성 질환 진단 : 신경퇴행성 질환의 조기 진단 및 모니터링을 가능하게 하는 보다 정교한 영상 시스템을 설계할 여지가 넓어지고 있습니다. 이미징을 강화하면 알츠하이머병과 파킨슨병과 같은 신경퇴행성 질환의 진단과 치료가 증상 발현 이전에 촉진될 수 있습니다.
• 개인화된 의료 : 추세가 개인화된 의료 전략으로 이동하는 동안 이러한 접근법에 뇌 이미지를 통합하는 것은 개별 뇌에 특화된 맞춤형 치료에 대한 움직임을 보여줍니다. 따라서 환자의 상태와 치료에 대한 반응을 정확하게 묘사하는 영상 시스템이 필요합니다.
• 원격 및 휴대용 이미징 솔루션 : 원격지 및 휴대용 뇌 이미지 솔루션을 제공하는 경향이 증가하고 진단 목적으로 충분한 서비스를 받지 못한 지역에 도달하는 데 도움이 됩니다. 원격지에서는 합리적인 가격으로 사용하기 편리한 이미징 시스템이 필요하며 큰 시장 기회를 제공합니다.
• 멀티모달 이미징 통합 : 뇌를 종합적으로 평가하기 위해 다양한 이미징 기술을 융합하는 능력은 개발의 큰 잠재력을 가지고 있습니다. MRI, PET, CT 등의 기기를 통합함으로써 진단의 향상, 나아가 환자의 결과 개선을 기대할 수 있습니다.
• 조사 및 임상시험 : 뇌 영상 분야에서의 조사 및 임상시험은 개선의 여지를 제공합니다. 이미징 기술의 개발이 진행되면, 뇌 기능의 해명이나 보다 효과적인 치료법의 개발에 있어서의 격차가 축소됩니다.

이러한 전략적 성장 기회는 뇌 영상 모달리티 시장의 미래를 형성하고 있습니다. 이해관계자가 혁신을 촉진하고, 진단 상황을 개선하고, 환자 경험을 향상시키기 위해서는 이러한 분야에 우선적으로 대응해야 합니다.

뇌영상 모달리티 시장 성장 촉진요인 및 과제

뇌 영상 모달리티 시장은 기술 향상, 경제 변동, 규제 정책 등 다양한 요인의 영향을 받고 있습니다. 시장의 이데올로기에 초점을 맞추고 성장을 가속하기 위해서는 이러한 요인을 이해하는 것이 필수적입니다.

뇌 영상 모달리티 시장을 견인하는 요인은 다음과 같습니다.

• 기술 진보: 초고해상도 MRI 및 인공지능 통합과 같은 혁신적인 이미징 기술의 개발이 시장 개척에 기여하고 있습니다. 이러한 기술은 진단 정확도를 향상시키고 뇌 연구 및 임상에서 새로운 응용을 가능하게 합니다.
• 신경질환 환자 증가 : 알츠하이머병 및 파킨슨병과 같은 신경질환의 이환율이 증가하는 것은 첨단 뇌 영상 진단 장치에 대한 수요 증가에 기여하고 있습니다. 이 동향에는 새로운 이미징 기술의 개발이 필요합니다.
• 정부 자금 및 연구 보조금 : 신경과학과 관련된 뇌영상에 대한 정부 자금 및 연구 보조금 증가는 신기술의 개발을 가능하게 합니다. 이러한 자금 지원으로 뇌 영상 분야의 기술 혁신이 가속화되고 있습니다.
• 의식 증가 및 조기 진단 : 신경 질환의 조기 진단 및 예방 의료에 대한 관심이 높아지는 경향이 있습니다. 이러한 의식의 고조와 조기 발견의 제창이, 고도의 뇌이미지 기술의 필요성을 뒷받침하고 있습니다.
• AI와 머신러닝의 통합 : 인공지능과 머신러닝의 활용으로 뇌 영상 기술의 데이터 분석 능력이 향상되었습니다. 이러한 진보는 더 나은 이미지 분석과 더 효과적인 진단으로 이어집니다.

뇌 영상 모달리티 시장의 과제는 다음과 같습니다.

• 첨단 이미징 시스템의 고비용 : 7T MRI와 같은 첨단 이미징 시스템의 엄청난 가격은 대중화를 막는 큰 장벽이 되었습니다. 이 과제는 환자와 의료 서비스 제공업체 모두에게 영향을 미치며 최신 이미지 기술의 적용을 제한합니다.
• 규제 및 승인 장애물: 새로운 이미징 시스템의 임상 평가와 승인은 기존 규제로 인해 어려운 경우가 많습니다. 이러한 장벽은 혁신적인 솔루션을 시장에 도입하는 일정을 늦출 수 있습니다.
• 데이터 프라이버시 및 보안에 대한 우려 : 뇌 영상 처리를 통한 개인 의료 정보의 취득 및 보유는 프라이버시 및 보안에 대한 우려를 야기합니다. 개인 데이터 보호 및 환자 개인 정보 보호법의 존중은 해결해야 할 중요한 문제입니다.

뇌 영상 모달리티 시장은 첨단 기술, 진단 지원에 대한 수요, 비용, 정책 및 데이터 보안과 관련된 새로운 문제로 인해 변화를 경험하고 있습니다. 이러한 촉진요인과 과제를 이해하는 것은 이 분야의 목표를 달성하고 환자에게 이익을 가져오는 데 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 뇌영상 모달리티 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 뇌영상 모달리티 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 뇌영상 모달리티 시장 : 제품별
  • CT장치
  • MRI 장치
  • PET장치
  • PET-CT 장치
  • PET-MRI 장치
• 세계의 뇌영상 모달리티 시장 : 환자유형별
  • 성인 및 아동
  • 유아
• 세계의 뇌영상 모달리티 시장 : 최종 용도별
  • 병원 및 진료소
  • 화상 진단센터
  • 외래수술센터(ASC)

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 뇌영상 모달리티 시장 : 지역별
• 북미의 뇌영상 모달리티 시장
• 유럽의 뇌영상 모달리티 시장
• 아시아태평양의 뇌영상 모달리티 시장
• 기타 지역의 뇌영상 모달리티 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 뇌영상 모달리티 시장의 성장 기회 : 제품별
  • 세계의 뇌영상 모달리티 시장의 성장 기회 : 환자유형별
  • 세계의 뇌영상 모달리티 시장의 성장 기회 : 최종 용도별
  • 세계의 뇌영상 모달리티 시장의 성장 기회 : 지역별
• 세계의 뇌영상 모달리티 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 뇌영상 모달리티 시장의 생산 능력 확대
  • 세계의 뇌영상 모달리티 시장에 있어서의 기업 합병 및 인수(M&A), 합작 사업
  • 인증 및 라이선싱

제7장 주요 기업 프로파일

• Aspect Imaging
• Canon
• Esaote
• Fujifilm Holdings Corporation
• General Electric

영문목차

The future of the global brain imaging modalities market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets. The global brain imaging modalities market is expected to reach an estimated $18.5 billion by 2031 with a CAGR of 4.8% from 2025 to 2031. The major drivers for this market are the growing prevalence of neurological disorders and traumatic brain injuries, ongoing technological advancements in brain imaging modalities and systems, and the rising popularity of molecular imaging in brain imaging.

• Lucintel forecasts that, within the product category, the MRI device is expected to witness the highest growth over the forecast period due to its increasing adoption to diagnose various medical conditions, such as brain tumors, strokes, and multiple sclerosis.
• Within the end use category, hospitals & clinics will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to rising prevalence of neurological disorders, strong adoption of new technologies, and existence of leading brain imaging modalities manufacturers in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Brain Imaging Modalities Market

The brain imaging modalities market has exciting emerging trends that are transforming diagnostic and therapeutic strategies. These trends are supported by technological improvements, the application of AI, and a rising interest in precision medicine. Knowledge of such trends is important for stakeholders who want to maintain their competitiveness and innovativeness in the industry.

• Artificial Intelligence: Starting from charting the cerebral non-invasive imaging modalities, it's worthwhile to note that non-invasive stimulated cerebral high-resolution imaging has lagged behind imaging techniques targeting segments such as MRI/PET, computed tomography, and other examination techniques. However, AI algorithms are applied to improve vast quantitative imaging analyses, thus enabling the detection of subtle changes in brain structures that could take a long time to notice. Enhancements and modeling structures with the aid of AI in brain imaging modalities are advancing. Along with this trend, more tailored and effective interventions are expected to emerge.
• Development of Advanced MRI Technologies: The comparatively new ultra-high field scanners (7T MRI and above) provide remarkably more resolution and detail than their predecessors. This advancement has changed how brain anatomy and pathologies are rendered through imaging, enhancing the capabilities of such studies. This is of great significance in the diagnosis of complex neurological disorders and for research-based studies in neuroimaging.
• Multimodal Imaging: More frequently, advanced imaging techniques such as PET, MRI, and CT are utilized in combination. This method effectively marries structural and functional assessments within the brain, leading to a comprehensive understanding of neurological illnesses that allows for effective treatment management and follow-up.
• Portable Imaging Devices: Portable and compact imaging devices are gaining traction among neuroimaging practitioners in less privileged remote and rural regions. The design of these devices focuses on portability and simplicity of operation, offering useful diagnostic services in areas that are out of reach of hospitals.
• Concern for Degenerative Diseases: Recently, efforts have been made towards developing imaging systems appropriate for degenerative brain disorders like Alzheimer's and Parkinson's. New imaging technologies are helping to manage these diseases better, even at an early stage, thereby enhancing treatment options.

These trends are significantly impacting the brain imaging modalities market by increasing the clarity of diagnosis, widening accessibility, and encouraging creativity. Technologies will continue to develop, and refined methodologies will emerge in the realm of brain imaging as new frontiers in research and clinical practice are opened.

Recent Developments in the Brain Imaging Modalities Market

Some new trends in brain imaging modalities are revolutionizing imaging tools for diagnosis. Advances in innovation and progress in research are leading to improved, effective, and affordable brain imaging techniques.

• Imaging Software Improved with Artificial Intelligence: Numerous existing brain imaging techniques are enhancing the detection of brain diseases, thanks to new algorithms in AI imaging. This allows for quick analysis of sophisticated imaging data, facilitating same-day diagnosis of functional abnormalities within the nervous system.
• Available MRI Systems with Greater Resolution: The emergence of sophisticated systems, such as 7T MRI systems, has improved imaging capabilities. The increased detail of both normal and abnormal brain morphology enhances basic science and clinical pathological assessments.
• Various Imaging Techniques Employed: Newer imaging techniques, like PET scans coupled with MRI, are emerging. With such imaging, precise diagnosis and proper therapeutic decisions can be made when faced with diverse types of neuropathy.
• Imaging Technologies in the Field: Unfortunately, conventional imaging techniques are still limited, which widens the gap between where care is offered and where it is needed, especially with diseases such as stroke. These small systems provide necessary imaging modalities to cover the gaps in healthcare.
• Trends in Functional Imaging: Enhancements in dynamic imaging techniques such as fMRIs, PETs, and MRIs provide detailed information regarding processes and connections within the brain. These enhancements lead to a better understanding of how the brain functions and enable therapies to be developed in a targeted manner.

In conclusion, these developments are changing the brain imaging modalities market by making diagnosis efficient and creating user-friendly interfaces. The progress of various imaging technologies is proving beneficial to both research and practice in neuroscience.

Strategic Growth Opportunities for Brain Imaging Modalities Market

The brain imaging modalities market is full of strategic growth opportunities related to key applications dominating various submarkets. These can be effectively exploited for the benefit of innovation in diagnosis, treatment, and research.

• Neurodegenerative Disease Diagnosis: There is increasing scope for designing more sophisticated imaging systems that enable early diagnosis and monitoring of neurodegenerative diseases. Enhanced imaging may facilitate the diagnosis and treatment of neurological diseases, such as Alzheimer's and Parkinson's, well before the onset of symptoms.
• Personalized Medicine: As the trend shifts toward personalized medicine strategies, the integration of brain imaging with these approaches indicates a move toward custom treatments specific to individual brains. This creates a need for imaging systems that accurately depict a patient's condition and how they respond to therapies.
• Remote and Portable Imaging Solutions: There is a growing trend toward offering remote and portable brain imaging solutions, which can help reach underserved areas for diagnostic purposes. There is a need for affordable and user-friendly imaging systems in remote locations, presenting a significant market opportunity.
• Multimodal Imaging Integration: The ability to blend various imaging techniques for an all-encompassing evaluation of the brain holds much promise for development. Integrating instruments such as MRI, PET, and CT can improve diagnosis and, consequently, outcomes for patients.
• Research and Clinical Trials: Research and clinical trials in the area of brain imaging are being stepped up, providing room for improvements. Advances in developing imaging technologies will reduce the gaps in understanding brain function and in creating more effective treatment methods.

These strategic growth opportunities are shaping the future of the brain imaging modalities market. These areas must be prioritized for stakeholders to foster innovation, improve the diagnostic landscape, and enhance patient experience.

Brain Imaging Modalities Market Driver and Challenges

The brain imaging modalities market is influenced by a variety of factors, including technological improvements, economic changes, and regulatory policies. It is imperative to understand these factors to focus on the ideologies of the market and foster growth.

The factors driving the brain imaging modalities market include:

• Technological Advancements: The development of innovative imaging technologies, such as ultra-high-resolution MRI and artificial intelligence integration, contributes to market growth. These technologies improve diagnostic accuracy and enable new applications in brain research and clinical practice.
• Increased Patients with Neurological Disorders: The rising incidence of neurological disorders, such as Alzheimer's and Parkinson's diseases, is contributing to increased demand for advanced brain imaging devices. This trend necessitates the development of new imaging techniques.
• Government Funding and Research Grants: An increase in government funding and research grants for neuroscience and related brain imaging is enabling the development of new technologies. This funding accelerates innovation within the brain imaging field.
• Growing Awareness and Early Diagnosis: There is a trend of increasing interest in early diagnosis and preventive care for neurological disorders. This heightened awareness and advocacy for early detection are driving the need for sophisticated brain imaging techniques.
• Integration of AI and Machine Learning: The use of artificial intelligence and machine learning has enhanced data interpretation capabilities in brain imaging technologies. These advancements lead to better image analysis and more effective diagnoses.

Challenges in the brain imaging modalities market include:

• High Costs of Advanced Imaging Systems: The exorbitant price of advanced imaging systems, like the 7T MRI machine, is a significant barrier to their adoption. This challenge affects both patients and healthcare service providers, limiting the application of the latest imaging technologies.
• Regulatory and Approval Hurdles: Clinical evaluation and approval for novel imaging systems are often arduous due to existing regulations. These barriers can delay the timeline for introducing innovative solutions to the market.
• Data Privacy and Security Concerns: The acquisition and retention of personal medical information through brain imaging processes raise concerns regarding privacy and security. Protecting personal data and respecting patients' privacy laws are critical issues that must be addressed.

The brain imaging modalities market is experiencing a shift due to advanced technology, the demand for diagnostic assistance, and emerging issues related to cost, policies, and data security. Understanding these drivers and challenges is essential for achieving the goals of this field and benefiting patients.

List of Brain Imaging Modalities Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain imaging modalities companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain imaging modalities companies profiled in this report include-

• Aspect Imaging
• Canon
• Esaote
• Fujifilm Holdings Corporation
• General Electric

Brain Imaging Modalities by Segment

The study includes a forecast for the global brain imaging modalities market by product, patient type, end use, and region.

Brain Imaging Modalities Market by Product [Analysis by Value from 2019 to 2031]:

• CT Devices
• MRI Devices
• PET Devices
• PET-CT Devices
• PET-MRI Devices

Brain Imaging Modalities Market by Patient Type [Analysis by Value from 2019 to 2031]:

• Adults & Pediatrics
• Infants

Brain Imaging Modalities Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers

Brain Imaging Modalities Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Brain Imaging Modalities Market

Recently, the brain imaging modalities market has undergone radical changes due to new technologies, improved funding for research, and enhancements in healthcare systems. These changes are improving the means of diagnosis and treatment for brain disorders. Companies in major economies are advancing imaging technologies to provide quicker and more accurate diagnostic options.

• United States: Significant advancements have been made with the assistance of functional MRI (fMRI) and recently acquired advanced PET scanners in the U.S. Imaging is becoming faster and more precise as new algorithms incorporating AI are developed. Additionally, there is an increased use of multiple imaging modalities to enhance neuroimaging of the brain, leading to better diagnoses of neurodegenerative diseases and mental disorders.
• China: China is also progressing in brain imaging capabilities by focusing on improved MRI and PET technologies. Innovations include high-field MRI systems and high-resolution molecular imaging systems. Increased government support for neuroscience studies is facilitating the development of new imaging systems that enable more precise and earlier diagnoses of brain disorders.
• Germany: Germany is making strides in MRI technology, including the manufacture of 7T MRI machines that allow for better resolution during imaging. The development of imaging software systems, such as reconstruction algorithms, along with the integration of machine learning, is improving diagnostic performance. These advancements align with German policies emphasizing increased research and development regarding the complexity of brain structures and functions.
• India: India is advancing in brain imaging by utilizing enhanced MRI and CT scanning technologies. Efforts are being made to expand the geographical coverage of imaging facilities to provide high-standard services in both urban and rural areas. There is a growing focus on developing affordable imaging modalities to meet the needs of a diverse population, thereby improving diagnosis and treatment.
• Japan: Japan is developing new technologies for brain imaging, particularly in PET and MRI systems. The focus is on integrating imaging with artificial intelligence to improve diagnostic quality and subsequent treatment. As a nation that values technology and innovation, Japan is leveraging advancements for brain imaging across various neurological disorders.

Features of the Global Brain Imaging Modalities Market

Market Size Estimates: Brain imaging modalities market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Brain imaging modalities market size by product, patient type, end use, and region in terms of value ($B).

Regional Analysis: Brain imaging modalities market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, patient types, end uses, and regions for the brain imaging modalities market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain imaging modalities market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain imaging modalities market by product (CT devices, MRI devices, PET devices, PET-CT devices, and PET-MRI devices), patient type (adults & pediatrics and infants), end use (hospitals & clinics, diagnostic imaging centers, and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Imaging Modalities Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Brain Imaging Modalities Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Brain Imaging Modalities Market by Product
  • 3.3.1: CT Devices
  • 3.3.2: MRI Devices
  • 3.3.3: PET Devices
  • 3.3.4: PET-CT Devices
  • 3.3.5: PET-MRI Devices
• 3.4: Global Brain Imaging Modalities Market by Patient Type
  • 3.4.1: Adults & Pediatrics
  • 3.4.2: Infants
• 3.5: Global Brain Imaging Modalities Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Diagnostic Imaging Centers
  • 3.5.3: Ambulatory Surgical Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Brain Imaging Modalities Market by Region
• 4.2: North American Brain Imaging Modalities Market
  • 4.2.1: North American Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.2.2: North American Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.3: European Brain Imaging Modalities Market
  • 4.3.1: European Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.3.2: European Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.4: APAC Brain Imaging Modalities Market
  • 4.4.1: APAC Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.4.2: APAC Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.5: ROW Brain Imaging Modalities Market
  • 4.5.1: ROW Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.5.2: ROW Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Imaging Modalities Market by Product
  • 6.1.2: Growth Opportunities for the Global Brain Imaging Modalities Market by Patient Type
  • 6.1.3: Growth Opportunities for the Global Brain Imaging Modalities Market by End Use
  • 6.1.4: Growth Opportunities for the Global Brain Imaging Modalities Market by Region
• 6.2: Emerging Trends in the Global Brain Imaging Modalities Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Imaging Modalities Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Imaging Modalities Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Aspect Imaging
• 7.2: Canon
• 7.3: Esaote
• 7.4: Fujifilm Holdings Corporation
• 7.5: General Electric